Sigachi Industries Limited has announced its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The Board of Directors also recommended a final dividend of Re. 0.10 per share and approved the appointment of new Cost and Internal Auditors for the fiscal year 2026-27. For the quarter ended March 31, 2026, the company reported standalone revenue from operations of 9,209.51 Lakhs and a standalone profit for the period of 490.50 Lakhs. Compared to the previous quarter (Q3 FY26), revenue increased by 0.07% while profit grew by 67.29%. Against the corresponding quarter of the previous year (Q4 FY25), revenue declined by 18.89% and profit decreased by 29.71%.

Sigachi Industries Limited is a prominent player in the pharmaceutical industry, specializing in the manufacture of high-quality cellulose-based excipients. The company is recognized for its technical expertise and commitment to excellence, providing a diverse range of products used in pharmaceutical formulations, food, and nutraceutical industries globally.

During 2025, the company navigated significant challenges, including a tragic fire accident at its Hyderabad plant in June 2025, which impacted operations and necessitated accounting for losses as an exceptional item. Despite these setbacks, the company has continued its expansion efforts and strategic initiatives to maintain its market position and operational continuity.

For the fiscal year ended March 31, 2026, the company reported a standalone loss of 7,954.65 Lakhs, primarily impacted by exceptional items related to the fire incident. The company maintains a strong equity base, and investors continue to monitor its recovery trajectory and long-term growth prospects as it restores full operational capacity and stabilizes its financial performance.